NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
CRYPTOMAP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CRYPTOMAP
ST13
US500000098748841Class
1, 5, 42, 44
Filing
98748841
Registration
7898128
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
08/19/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
09/13/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
16
Owner location
Cambridge, GB
Examiner
OAKES, JEFFREY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Epitopea Ltd.
Epitopea Inc.
Representatives
Scott D. Locke Dorf Nelson & Zauderer LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicalsreagents and substancesbeing diagnostic reagentsbuffersnucleic acidspeptidesantibodies and immunological peptides for medical research; antibodies for scientific purposes; immunoassay reagentsother than for medical or veterinary use; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use composed primarily of nucleic acidspeptidesantibodiesbuffers and reagents; proteinsmonoclonal and polyclonal antibodiesimmunological peptides for scientific or research use; nucleotides for scientific and research use
Class 5
Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic usesprotein arrays for medical diagnosis purposes; diagnostic reagents for medical use; diagnostic and testing preparations for clinicalmedical and medical laboratory usediagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in oncology and immunology testing for medical purposes; diagnostic test kits for medical purposesdiagnostic kits comprising diagnostic agentspreparations and substances for medical use; antibodies for medical purposes; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use
Class 42
Research and development in the fields of medicine in the nature of oncology and immunology; scientific research for medical purposes in the field of oncology; mining in the field of biology; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data on oncology and immunology; biomedical research services conducted using databases; consultancyinformation and advisory services in the fields of oncology and immunology
Class 44
Services in the field of oncology and immunologymedical analysis services for the diagnosis of cancer and immunological disorders; medical screening services in the fields of oncology and immunology.
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/25/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/25/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2025
GNRT
NON-FINAL ACTION E-MAILED
03/21/2025
CNRT
NON-FINAL ACTION WRITTEN
03/21/2025
DOCK
ASSIGNED TO EXAMINER
03/13/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2025
NWAP
NEW APPLICATION ENTERED
09/13/2024
Continuous trademark protection
Get notified about every new filing that threatens CRYPTOMAP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.